Journal of Cerebral Blood Flow & Metabolism · 2017 · 64 citations · 41 references
MedicineNeuroscienceNeurosurgeryCerebrovascular NeurosurgeryCerebrovascular SurgeryInterventional CardiologyAcute Ischemic StrokeAcute Stroke ManagementCerebrovascular DiseaseNeuroprotectionStrokeStroke PharmacotherapyAcute Ischemic Stroke InterventionAcute Ischemic Stroke TreatmentCerebral Ischemia NeuroprotectionDose ResponseEndovascular Stroke TreatmentInverted U-shaped Dose-response ModelsNeuroprotective ResponsesStroke Neuroprotection
Large vessel ischemic stroke represents the most disabling subtype. While t-PA and endovascular thrombectomy can recanalize the occluded vessel, good clinical outcomes are not uniformly achieved. We propose that supplementing endovascular thrombectomy with superselective intra-arterial (IA) verapamil immediately following recanalization could be safe and effective. Verapamil, a calcium channel blocker, has been shown to be an effective IA adjunct in a pre-clinical mouse focal ischemia model. To demonstrate translational efficacy, mechanism, feasibility, and safety, we conducted a group of translational experiments. We performed in vivo IA dose–response evaluation in our animal stroke model with C57/Bl6 mice. We evaluated neuroprotective mechanism through in vitro primary cortical neuron (PCN) cultures. Finally, we performed a Phase I trial, SAVER-I, to evaluate feasibility and safety of administration in the human condition. IA verapamil has a likely plateau or inverted-U dose–response with a defined toxicity level in mice (LD 50 16–17.5 mg/kg). Verapamil significantly prevented PCN death and deleterious ischemic effects. Finally, the SAVER-I clinical trial showed no evidence that IA verapamil increased the risk of intracranial hemorrhage or other adverse effect/procedural complication in human subjects. We conclude that superselective IA verapamil administration immediately following thrombectomy is safe and feasible, and has direct, dose–response-related benefits in ischemia.
41
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
Olvert A. Berkhemer, Puck Fransen, Debbie Beumer et al. · New England Journal of Medicine · 2014 · 6.6K citations · Full text
Medicine, Neurology, Neurosurgery +14